Literature DB >> 28522922

Taking the vehicle out of drug delivery.

Jianliang Shen1, Joy Wolfram1, Mauro Ferrari1,2, Haifa Shen1,3.   

Abstract

Entities:  

Year:  2017        PMID： 28522922      PMCID： PMC5431297          DOI： 10.1016/j.mattod.2017.01.013

Source DB:  PubMed          Journal:  Mater Today (Kidlington)        ISSN： 1369-7021            Impact factor:   31.041


× No keyword cloud information.
  8 in total

Review 1.  Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.

Authors:  Y D Jung; L M Ellis
Journal:  Int J Exp Pathol       Date:  2001-12       Impact factor: 1.925

2.  Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer.

Authors:  M R Green; G M Manikhas; S Orlov; B Afanasyev; A M Makhson; P Bhar; M J Hawkins
Journal:  Ann Oncol       Date:  2006-06-01       Impact factor: 32.976

3.  Antibody-Targeted Chemotherapy for the Treatment of Melanoma.

Authors:  Wendy K Nevala; Sarah A Buhrow; Daniel J Knauer; Joel M Reid; Elena A Atanasova; Svetomir N Markovic
Journal:  Cancer Res       Date:  2016-04-28       Impact factor: 12.701

4.  Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.

Authors:  B J Vilner; C S John; W D Bowen
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701

5.  Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate.

Authors:  S Liao; Y Umekita; J Guo; J M Kokontis; R A Hiipakka
Journal:  Cancer Lett       Date:  1995-09-25       Impact factor: 8.679

6.  Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy.

Authors:  Ping Huang; Dali Wang; Yue Su; Wei Huang; Yongfeng Zhou; Daxiang Cui; Xinyuan Zhu; Deyue Yan
Journal:  J Am Chem Soc       Date:  2014-08-07       Impact factor: 15.419

Review 7.  Cell-penetrating, guanidinium-rich molecular transporters for overcoming efflux-mediated multidrug resistance.

Authors:  Jessica R Vargas; Erika Geihe Stanzl; Nelson N H Teng; Paul A Wender
Journal:  Mol Pharm       Date:  2014-05-09       Impact factor: 4.939

8.  Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy.

Authors:  Joo Eun Chung; Susi Tan; Shu Jun Gao; Nunnarpas Yongvongsoontorn; Soon Hee Kim; Jeong Heon Lee; Hak Soo Choi; Hirohisa Yano; Lang Zhuo; Motoichi Kurisawa; Jackie Y Ying
Journal:  Nat Nanotechnol       Date:  2014-10-05       Impact factor: 39.213
  8 in total
  10 in total

1.  Clinical Cancer Nanomedicine.

Authors:  Joy Wolfram; Mauro Ferrari
Journal:  Nano Today       Date:  2019-03-06       Impact factor: 20.722

Review 2.  Lipoprotein-based drug delivery.

Authors:  Sara Busatto; Sierra A Walker; Whisper Grayson; Anthony Pham; Ming Tian; Nicole Nesto; Jacqueline Barklund; Joy Wolfram
Journal:  Adv Drug Deliv Rev       Date:  2020-08-11       Impact factor: 15.470

Review 3.  Graphene and other 2D materials: a multidisciplinary analysis to uncover the hidden potential as cancer theranostics.

Authors:  Laura Fusco; Arianna Gazzi; Guotao Peng; Yuyoung Shin; Sandra Vranic; Davide Bedognetti; Flavia Vitale; Acelya Yilmazer; Xinliang Feng; Bengt Fadeel; Cinzia Casiraghi; Lucia Gemma Delogu
Journal:  Theranostics       Date:  2020-04-07       Impact factor: 11.556

4.  Extracellular vesicle therapeutics from plasma and adipose tissue.

Authors:  Dalila Iannotta; Man Yang; Christian Celia; Luisa Di Marzio; Joy Wolfram
Journal:  Nano Today       Date:  2021-04-27       Impact factor: 18.962

5.  Self-Assembled Nanobodies as Selectively Targeted, Nanostructured, and Multivalent Materials.

Authors:  Laura Sánchez-García; Eric Voltà-Durán; Eloi Parladé; Elisa Mazzega; Alejandro Sánchez-Chardi; Naroa Serna; Hèctor López-Laguna; Mara Mitstorfer; Ugutz Unzueta; Esther Vázquez; Antonio Villaverde; Ario de Marco
Journal:  ACS Appl Mater Interfaces       Date:  2021-06-15       Impact factor: 10.383

6.  Intelligent nanogels with self-adaptive responsiveness for improved tumor drug delivery and augmented chemotherapy.

Authors:  Xin Li; Helin Li; Changchang Zhang; Andrij Pich; Lingxi Xing; Xiangyang Shi
Journal:  Bioact Mater       Date:  2021-03-24

7.  Ion-dependent slow protein release from in vivo disintegrating micro-granules.

Authors:  Patricia Álamo; Eloi Parladé; Hèctor López-Laguna; Eric Voltà-Durán; Ugutz Unzueta; Esther Vazquez; Ramon Mangues; Antonio Villaverde
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 8.  Research Progress of Conjugated Nanomedicine for Cancer Treatment.

Authors:  Bin Zhao; Sa Chen; Ye Hong; Liangliang Jia; Ying Zhou; Xinyu He; Ying Wang; Zhongmin Tian; Zhe Yang; Di Gao
Journal:  Pharmaceutics       Date:  2022-07-21       Impact factor: 6.525

Review 9.  Multifunctional magnetic iron oxide nanoparticles: an advanced platform for cancer theranostics.

Authors:  Shengzhe Zhao; Xujiang Yu; Yuna Qian; Wei Chen; Jianliang Shen
Journal:  Theranostics       Date:  2020-05-15       Impact factor: 11.556

10.  The Poly-Histidine Tag H6 Mediates Structural and Functional Properties of Disintegrating, Protein-Releasing Inclusion Bodies.

Authors:  Julieta María Sánchez; José Vicente Carratalá; Naroa Serna; Ugutz Unzueta; Verónica Nolan; Alejandro Sánchez-Chardi; Eric Voltà-Durán; Hèctor López-Laguna; Neus Ferrer-Miralles; Antonio Villaverde; Esther Vazquez
Journal:  Pharmaceutics       Date:  2022-03-10       Impact factor: 6.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.